View
7
Download
0
Category
Preview:
Citation preview
Stericycle, Inc. – Q1 2015 NASDAQ: SRCL
2
Forward - Looking Statements
This presentation may contain forward-looking statements that involve a number of risks and uncertainties and our actual results could differ significantly from expected results. Potential risks and uncertainties include difficulties in completing the integration of acquired businesses, changes in governmental regulation of medical waste collection and treatment, and increases in transportation and other operating costs, as well as various other factors described in our public filings with the U.S. Securities and Exchange Commission. Accordingly, past financial performance should not be considered a reliable indicator of future performance, and historical trends should not be used to anticipate future trends or results. For a definition of terms used throughout this presentation please see the last page on our website presentation.
3
Stericycle Overview
• A global business-to-business solutions provider • Specializing in complex and highly regulated arenas
– Regulated Waste Management & Compliance Solutions
– Brand Protection Services
– Environmental & Sustainable Solutions
– Patient & Customer Communications Solutions
• Supporting healthcare and commercial organizations big and small
4
– Regulated and Compliance Solutions • Medical Waste Services • Compliance Programs • Sharps Management Service • Pharmaceutical Waste Disposal • Hazardous Waste Services • Communication Solutions
– Recall and Returns Management Solutions
• Notification, Communication, Retrieval, Disposal & Compliance
Broad Range of High Quality Services
5
Market Leadership
Total Estimated Global Market Size: $19.5 billion*
Note: Includes global markets with established regulatory framework for medical waste plus global markets in which Stericycle operates for recall/returns, hazardous waste and communication services. Source: Various industry studies and management estimates (including ancillary services & products).
Stericycle 13%
Onsite Management
and Other Competitors
87%
6
Loyal Customer Base
• Highly regulated industry – U.S. Market: EPA, DEA, FDA, OSHA, DOT, State/Local;
International markets have similar agencies
• Insulated from economic cycles • Diverse customer base with largest customer counting for
less than 2% of revenues − Hospitals, medical and dental offices, offsite and alternate care
providers, pharmaceutical manufacturers, biomedical/biotech companies, laboratories, pharmacies, corporate sites, retailers, universities, municipalities, and manufacturers
• Predictable revenues: over 95% of revenues are under long term contracts
• Contracts generally include pass through price increase provisions
7
Growth Strategy
Acquisitions Enhance Service
Platforms
International Expansion
Leverage Customer
Relationship
8
Focus on Small Customers
• Small account customers generate gross margins higher than large account customers
• Small account customers are more likely to outsource and are easier to up-sell
42.4% Gross Margin 21.0% Gross Margin
1996 % Revenue Mix* Q1- 2015
Large Account Customers
67%
Small Account Customers
33%
Large Account Customers
37% Small Account Customers
63%
*Note: Domestic SQ and LQ revenue mix
9
Medical Waste Services
Compliant management of medical waste to protect workers, reduce cross contamination risk, and improve sustainability
• Necessary regulated services • Large diverse customer base • Worldwide market opportunity • Foundation for a portfolio of
regulated waste and compliance services
• Low cost operator • Attractive margins
10
Compliance Solutions
Promotes safety, compliance, and best practices for healthcare employees - Steri-Safe OSHA &
HIPAA - Clinical Services
(International) - Medical & Pharmaceutical
Waste • Subscription compliance
resources • Significant up-sell
opportunities • International expansion
MyStericycle.com Consulting Services
Clinical Services
11
Sharps Management Service
Provides a safer workplace by reducing the infection risk from inadvertent needle sticks and supports sustainability efforts
• Turnkey integrated sharps safety solution to manage & collect reusable sharps containers
• Synergy with existing transportation and treatment Infrastructure
• International expansion opportunities
12
Pharmaceutical Waste Disposal
Protects the environment through proper handling, segregation, transportation and disposal of pharmaceutical waste
• Turnkey integrated pharmaceutical waste management system for healthcare
• Synergy with existing infrastructure
13
Hazardous Waste Management Services
Minimizes environment impact with the proper segregation, transportation and disposal of a wide variety of hazardous materials
• Turnkey solutions for the retail and healthcare industry
• Creative solutions to support corporate sustainability goals
• Leverages logistics and waste management expertise
14
Global Presence
Network of Premier Waste Management Assets Integrated Network
Collection/Transfer Processing/TSDF
15
Communication Solutions
Live voice telephone answering service, automated appointment reminders, appointment scheduling, physician referrals, post discharge and wellness calls
• Essential service for current customer base
• Serving medical offices, clinics, community care centers, hospitals, and commercial businesses
• Leverages recall call center expertise
16
LQ/SQ Opportunity
LQ – Hospital Example SQ – Physician Practice Example
Total Revenue Opportunity: $185k - $230k
6X Med Waste Revenue
Total Revenue Opportunity: $10k - $13.6k
10X Med Waste Revenue
Communication Solutions
Haz Waste
Sharps Management Med Waste
Revenue Range
$75k - $100k
$10k - $15k
$35k - $40k
$30k - $35k
Rx Waste $35k - $40k
Communication Solutions • Secure Messaging • Automated
Reminder • After Hours • Daytime Call
Management
$6.3k - $8.8k
Revenue Range
$1.5k - $1.8k
$1.0k - $1.5k
Rx Waste
Med Waste
Compliance
$1.2k - $1.5k
17
Recall and Returns Management Solutions
Comprehensive notification, returns or recall, and call center solutions to protect and build brands • Reduces business and
consumer risk • Serving manufactures of all
types, hospitals, distributors, and retail pharmacies
• Growing capability in global markets
18
Acquisitions
• Proven integrator having successfully completed 407 acquisitions since 1993
• Current worldwide acquisition pool represents more than $100 million in revenues
• Purchase price is based on IRR/multiples of EBITDA and depends on the risk and quality of the assets purchased
19
$0.30 $0.37 $0.54 $0.73 $0.88 $1.04 $1.16 $1.42 $1.73 $2.09
$2.52 $2.85 $3.30
$3.75 $4.27
2000$0.18
2001$0.17
2002$0.51
2003$0.71
2004$0.85
2005$0.74
2006$1.16
2007$1.32
2008$1.68
2009$2.03
2010$2.39
2011$2.69
2012$3.08
2013$3.56
2014$3.79
$75 $88 $104 $126 $147 $167 $202 $240 $280 $325
$391 $444
$499 $557
$615
2000$63
2001$73
2002$101
2003$126
2004$146
2005$167
2006$202
2007$225
2008$274
2009$315
2010$371
2011$424
2012$469
2013$536
2014$556
$324 $359 $402 $453 $516 $610 $790 $933
$1,084 $1,178 $1,439
$1,676 $1,913
$2,143
$2,556
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Proven Financial Performance
CAGR
15.9%
CAGR Non-GAAP EBIT
16.2%
CAGR Non-GAAP EPS
20.9%
Revenue
EPS (non-GAAP)
EBIT (non-GAAP)
GAAP EBIT
GAAP EPS
20
Capitalization
($ in millions) Dec 31, 2013 Dec 31, 2014 Mar 31, 2015
Current Portion of Long Term Debt $150.4 $132.0 $113.2
Revolver / Term Loan $272.4 $460.0 $425.6
Private Placement $750.0 $750.0 $750.0
Other Debt $258.3 $317.3 $286.6
Total Long Term Debt $1,280.7 $1,527.3 $1,462.2
Common Equity* $1,750.5 $1,895.0 $1,930.9
Total Capitalization $3,181.5 $3,554.2 $3,506.3
Debt to EBITDA 2.06X 2.22X 2.07X
* Common Equity is defined as Total Shareholders’ Equity less noncontrolling interests.
21
Investment Highlights
• Attractive broad range of niche services
• Emerging global market
• Low cost provider
• Diverse customer base
• Strong financial performance and strong free cash flow
• Demonstrated growth strategy
• Successful in integrating acquisitions and improve margins
• Proven, experienced, worldwide management team
Stericycle, Inc. NASDAQ: SRCL
Appendix
23
Financial Footnotes
EBIT NOTES • 2000-2001: Adjusted for pro-forma adoption of new accounting standards to
cease amortization of goodwill. • 2006-2015: Includes expensing of stock compensation. • 2000-2015: Excludes integration related costs, write-off of fixed assets and other
non-operational items. • 2009-2015: Excludes expenses associated with acquisitions/business
combinations.
EPS NOTES • Adjusted for 2-for-1 stock split in May 2002 and in May 2007. • Non-GAAP EPS is adjusted for: Acquisition and integration related costs, bond
buyback premium & bank loan financing fees, tax adjustment to fully taxed, non-cash fixed assets write-offs, legal settlements, non-cash write-down of investments, goodwill amortization pre-2002, insurance proceeds, note receivable write-down, gain on divestiture of assets, impairment of intangible assets, restructuring and litigation costs. Expensing of stock compensation is NOT part of the adjustments.
24
Definition of Terms
This presentation uses certain abbreviations:
CAGR means compound annual growth rate
EBIT means earnings before interest expense and income taxes
EPS means earnings per share diluted
GAAP means United States generally accepted accounting principles
LQ refers to a Large Account customer
SQ refers to a Small Account customer
Free Cash Flow means cash from operations less capital expenditures
Recommended